Global Head of Evidence Generation - International

Ipsen Group; Paris; Hybride; EUR 120 000 - 180 000; Plein temps

Avantages offerts par ce poste

Hybrid work model

Résumé du poste

Ipsen Pharma (SAS) seeks a Head of Evidence Generation – International to shape and execute the evidence strategy across Oncology, Rare Diseases and Neuroscience. You will drive Phase IV, observational studies, and real-world evidence to support regulatory and payer decisions.

The role requires senior leadership, scientific rigor, and global collaboration with cross-functional teams to ensure alignment with local market needs and lifecycle goals.

Qualifications

• Advanced degree in life sciences, medicine, epidemiology, or related field.
• Extensive experience in medical affairs, clinical research, RWE or HEOR within pharma.
• Proven track record leading regional/global evidence generation strategies.

Responsabilités

• Develop and lead international evidence generation strategy (Phase IV, ISS, RWE).
• Oversee planning, execution and reporting of clinical studies and health outcomes research.
• Collaborate with medical, market access and HEOR teams to align evidence with objectives.

Connaissances

RWE & HEOR

Leadership & Strategy

Clinical Research

Regulatory & Ethics

Data Analytics (SAS/R)

Formation

MD/PhD/PharmD or MSc Epidemiology

Outils

SAS

R

Excel

Description du poste

Ipsen Pharma (SAS) seeks a Head of Evidence Generation – International to shape and execute the evidence strategy across Oncology, Rare Diseases and Neuroscience. You will drive Phase IV, observational studies, and real-world evidence to support regulatory and payer decisions.

The role requires senior leadership, scientific rigor, and global collaboration with cross-functional teams to ensure alignment with local market needs and lifecycle goals.